drugset / Trial / NCT00813826
Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of SLC022 in treating pain associated with post-herpetic neuralgia (PHN) in recently diagnosed patients.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-10
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLC022 | Unknown | 300 mg | Oral |